United States· US:87845-101_56812625-7eac-6a25-e063-6294a90a23fe
Yodo Salil
A medicinal product containing camphor, (-)-; methyl salicylate; povidone-iodine, registered in United States by Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia. LTDA..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CAMPHOR, (-)-; METHYL SALICYLATE; POVIDONE-IODINE
- Manufacturer
- Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia. LTDA.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 1
- ndc1187845-101-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6dc8369-85ad-45ee-8460-4966545d0702 GET /v1/drugs/b6dc8369-85ad-45ee-8460-4966545d0702?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; 8; 4.88",
"substance": "CAMPHOR, (-)-; METHYL SALICYLATE; POVIDONE-IODINE",
"productndc": "87845-101",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about camphor, (-)-; methyl salicylate; povidone-iodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.